Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

International working group identifies need for newborn screening for mucopolysaccharidosis type I but states that existing hurdles must be overcome

Research output: Contribution to journalReviewResearchpeer-review

DOI

  1. Paediatric hepatitis B and hepatitis C virus infections: an observational study of a Danish cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Infectious diseases detected by screening after arrival to Denmark in internationally adopted children

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Is earlier better when it comes giving caffeine to preterm infants or are we risking unnecessary treatment and serious harm?

    Research output: Contribution to journalEditorialResearchpeer-review

  4. Predicting respiratory distress syndrome at birth using a fast test based on spectroscopy of gastric aspirates. 2. Clinical part

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Impaired lipolysis in propionic acidemia: A new metabolic myopathy?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Increased risk of sudden death in untreated Primary Carnitine Deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Danish expanded newborn screening is a successful preventive public health programme

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Rossella Parini
  • Alexander Broomfield
  • Maureen A Cleary
  • Linda De Meirleir
  • Maja Di Rocco
  • Waseem M Fathalla
  • Nathalie Guffon
  • Christina Lampe
  • Allan M Lund
  • Maurizio Scarpa
  • Anna Tylki-Szymańska
  • Jiří Zeman
View graph of relations

AIM: Mucopolysaccharidosis type I is a lysosomal storage disorder that can result in significant disease burden, disability and premature death, if left untreated. The aim of this review was to elaborate on the diagnosis of mucopolysaccharidosis type I and the pros and cons of newborn screening.

METHODS: An international working group was established to discuss ways to improve the early diagnosis of mucopolysaccharidosis type I. It consisted of 13 experts in paediatrics, rare diseases and inherited metabolic diseases from Europe and the Middle East.

RESULTS: It is becoming increasingly clearer that the delay between symptom onset and clinical diagnosis is considerable for mucopolysaccharidosis type I and other rare lysosomal storage disorders, despite numerous awareness campaigns since therapies became available. Diagnosis currently depends on recognising the signs and symptoms of the disease. The practice of newborn screening, which is being explored by pilot programmes around the world, enables early diagnosis and consequently early treatment. However, these studies have highlighted numerous new problems and pitfalls that must be faced before newborn screening becomes generally available.

CONCLUSION: Newborn screening for mucopolysaccharidosis type I offers the potential for early diagnosis and early pre-symptomatic treatment, but existing hurdles need to be overcome.

Original languageEnglish
JournalActa paediatrica
Volume107
Issue number12
Pages (from-to)2059-2065
Number of pages7
ISSN1651-2227
DOIs
Publication statusPublished - Dec 2018

ID: 56309807